1. Menillo, AM, Lee, L, Pearson-Shaver, AL. Atrial Septal Defects. StatPearls Publ. Published online 2020.
Google Scholar2. Post, MC . Association between pulmonary hypertension and an atrial septal defect. Published online 2013:331-332. doi:10.1007/s12471-013-0432-9
Google Scholar | Crossref3. Savale, L, Weatherald, J, Jaïs, X, et al. Acute decompensated pulmonary hypertension. Eur Respir Rev. 2017;26(146):1-12. doi:10.1183/16000617.0092-2017
Google Scholar | Crossref4. Schamroth, CL, Med, M, Sapeli, P, et al. Pulmonary Arterial Thrombosis in Secundum Atrial Septal Defect.
Google Scholar5. Toyono, M . Pulmonary arterial hypertension in adults with atrial septal defect. JCCASE. 2012;6(1):e32-e33. doi:10.1016/j.jccase.2012.04.005
Google Scholar | Crossref6. Baumgartner, H, De Backer, J, Babu-Narayan S, V, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. Published online 2020:1-83. doi:10.1093/eurheartj/ehaa554
Google Scholar | Crossref7. D’Alto, M, Mahadevan, VS. Pulmonary arterial hypertension associated with congenital heart disease. Eur Respir Rev. 2012;21(126):328-337. doi:10.1183/09059180.00004712
Google Scholar | Crossref | Medline8. Nashat, H, Montanaro, C, Li, W, et al. Atrial septal defects and pulmonary arterial hypertension. J Thorac Dis. 2018;10(4):S2953-S2965. doi:10.21037/jtd.2018.08.92
Google Scholar | Crossref | Medline9. Gabriels, C, De, Meester P, Pasquet, A, et al. A different view on predictors of pulmonary hypertension in secundum atrial septal defect. Int J Cardiol. 2014;176(3):833-840. doi:10.1016/j.ijcard.2014.08.009
Google Scholar | Crossref | Medline | ISI10. Galiè, N, Humbert, M, Vachiery, JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2016;37(1):67-119. doi:10.1093/eurheartj/ehv317
Google Scholar | Crossref | Medline11. Cheng, TO . Mitral valve prolapse related to geometric changes of the heart in cases of progressive muscular dystrophy. Clin Cardiol. 1985;8(1):63-63. doi:10.1002/clc.4960080113
Google Scholar | Crossref | Medline12. Condon, DF, Nickel, NP, Anderson, R, Mirza, S, De, VA, Perez, J. Open Peer Review The 6th World Symposium on Pulmonary Hypertension: what’s old is new. F1000Research. 2019;8:1-8. https://doi.org/10.12688/f1000research.18811.1
Google Scholar | Crossref13. Dixon, DD, Trivedi, A, Shah, SJ. Combined post- and pre-capillary pulmonary hypertension in heart failure with preserved ejection fraction. Heart Fail Rev. Published online 2015. doi:10.1007/s10741-015-9523-6
Google Scholar | Crossref14. Klinger, JR, Elliott, CG, Levine, DJ, et al. Therapy for Pulmonary Arterial Hypertension in Adults: Update of the CHEST Guideline and Expert Panel Report. Chest. 2019;155(3):565-586. doi:10.1016/j.chest.2018.11.030
Google Scholar | Crossref | Medline15. Zeng, WJ, Lu, XL, Xiong, CM, et al. The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease. Clin Cardiol. 2011;34(8):513-518. doi:10.1002/clc.20917
Google Scholar | Crossref | Medline16. H.Oppie L . Drugs for The Heart. 8th ed. Elsevier Saunders; 2013.
Google Scholar17. Stout, KK, Daniels, CJ, Aboulhosn, JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Vol 139; 2019. doi:10.1161/CIR.0000000000000603
Google Scholar | Crossref18. Harris, KM, Aeppli, DM, Carey, CF. Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity. Am Heart J. 2005;150(5):1106.e1–1106.e6. doi:10.1016/j.ahj.2005.07.023
Google Scholar | Crossref | Medline19. Humbert, M, Morrell, NW, Archer, SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12 SUPPL.):S13-S24. doi:10.1016/j.jacc.2004.02.029
Google Scholar | Crossref20. Ortel, TL, Neumann, I, Ageno, W, et al. American society of hematology 2020 guidelines for management of venous thromboembolism: Treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693-4738. doi:10.1182/bloodadvances.2020001830
Google Scholar | Crossref | Medline21. Simonneau, G, Torbicki, A, Dorfmüller, P, Kim, N. The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2017;26(143):1-14. doi:10.1183/16000617.0112-2016
Google Scholar | Crossref22. Salehi, S, Reddy, S, Gholamrezanezhad, A. Long-term Pulmonary Consequences of Coronavirus Disease 2019 (COVID-19): What We Know and What to Expect. J Thorac Imaging. 2020;35(4):W87-W89. doi:10.1097/RTI.0000000000000534
Google Scholar | Crossref | Medline23. John J., Ryan . The Impact of COVID-19 on Pulmonary Hypertension. Am Coll Cardiol. Published online 2020.
Google Scholar24. Nalbandian, A, Sehgal, K, Gupta, A, et al. Post-acute COVID-19 syndrome. Nat Med. Published online 2021. doi:10.1038/s41591-021-01283-z
Google Scholar | Crossref | Medline